The global AI in Pathology Market is shaped by changing industry requirements and the level of demand across its key applications. Polaris Market Research has prepared this report to provide an overview of the industry and its expected development over the coming years. It looks at the factors that influence market activity and explains how revenue is spread across different parts of the...
The Anti-Radiation Drugs Market is expanding as governments, defense agencies, oncology centers, and pharmaceutical developers prioritize medical countermeasures that mitigate cellular damage from ionizing radiation. Growth is supported by rising cancer radiotherapy volumes, heightened geopolitical and nuclear safety preparedness, national emergency stockpiling programs, and advancements in...
Molecular Robotics draws direct inspiration from nature's own nanomachines, such as kinesin, myosin, and ATP synthase. By studying how biological protein motors convert chemical energy into mechanical work inside living cells, scientists engineer synthetic counterparts with tailored capabilities.
The global molecular robotics market size is projected to reach US$ 11.67 billion by 2034 from...
The global Clinical Trial Supplies market is witnessing steady expansion as pharmaceutical and biopharmaceutical companies increase research and development activities and the number of clinical trials continues to grow. Rising drug development costs and the increasing prevalence of chronic diseases are contributing to demand for efficient clinical trial supplies management. Clinical trial...
The global Cell and Gene Therapy Market is expanding as pharmaceutical and biotechnology companies increase their focus on advanced treatments for chronic diseases, genetic disorders, oncology, rare diseases, and personalized medicine. Increasing research activity, biotechnology investments, regulatory support, and technological innovation are contributing to the development and adoption of...
The Global Specialty Pharmaceuticals Market size is projected to reach US$ 2,334.45 billion by 2034 from US$ 293.84 billion in 2025. The market is anticipated to register a CAGR of 25.90% during the forecast period 2026–2034. The growing prevalence of chronic and rare diseases, increasing demand for advanced biologic therapies, rising investments in pharmaceutical research and...
The global injectable drug delivery market is witnessing significant growth, supported by the increasing prevalence of chronic diseases, rising demand for biologics, and technological advancements in drug administration systems. The injectable drug delivery market size is projected to reach US$ 84.08 billion by 2031 from US$ 48.89 billion in 2024. The market is expected to register a CAGR of...
The global Clinical Trial Supplies market is witnessing steady expansion as pharmaceutical and biopharmaceutical companies increase research and development activities and the number of clinical trials continues to grow. Rising drug development costs and the increasing prevalence of chronic diseases are contributing to demand for efficient clinical trial supplies management. Clinical trial...
The Bioconjugation Market is witnessing substantial growth due to the increasing adoption of targeted therapies, expanding biopharmaceutical research, and rising demand for precision medicine. Bioconjugation technologies play a crucial role in linking biomolecules such as antibodies, peptides, proteins, and drugs to improve therapeutic efficacy and specificity. The market is expected to grow...
The Activin Signaling Inhibitors Market is covered by Business Market Insights with 2025 as the base year and 2026–2033 as the forecast period. The retrieved public source material for this batch did not expose all three headline values required for a verified numerical opening, so no market-size figure or CAGR is inferred.
Market growth is best read through customer demand, operating...
Global Nuclear Medicine Market Set for Transformational Expansion as Precision Oncology, Theranostics, and Advanced Radioisotopes Reshape Modern Clinical Interventions
The global nuclear medicine landscape is undergoing an unprecedented paradigm shift, evolving from a supplementary diagnostic modality into a central pillar of personalized, targeted therapeutics. Historically leveraged...
According to the latest report published by Data Bridge Market Research, the Nanobody Therapeutics Market
CAGR ValueAs per Data Bridge Market Research analysis The Nanobody Therapeutics Market was valued at USD 2.34 billion in 2025 and is projected to reach USD 7.15 billion by 2033, growing at a CAGR of 15.00% from 2026 to 2033.The winning Nanobody Therapeutics Market report...